JP2012051888A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012051888A5 JP2012051888A5 JP2011191990A JP2011191990A JP2012051888A5 JP 2012051888 A5 JP2012051888 A5 JP 2012051888A5 JP 2011191990 A JP2011191990 A JP 2011191990A JP 2011191990 A JP2011191990 A JP 2011191990A JP 2012051888 A5 JP2012051888 A5 JP 2012051888A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- lateral sclerosis
- amyotrophic lateral
- agent according
- gene mutation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37955810P | 2010-09-02 | 2010-09-02 | |
| US61/379,558 | 2010-09-02 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012051888A JP2012051888A (ja) | 2012-03-15 |
| JP2012051888A5 true JP2012051888A5 (enExample) | 2014-10-16 |
| JP5835729B2 JP5835729B2 (ja) | 2015-12-24 |
Family
ID=45773059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011191990A Expired - Fee Related JP5835729B2 (ja) | 2010-09-02 | 2011-09-02 | 筋萎縮性側索硬化症の予防および治療用医薬組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9856210B2 (enExample) |
| EP (1) | EP2611437B1 (enExample) |
| JP (1) | JP5835729B2 (enExample) |
| WO (1) | WO2012029994A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201507829SA (en) | 2013-03-21 | 2015-12-30 | Univ Kyoto | Pluripotent stem cell for neuronal differentiation induction |
| CN104045598B (zh) * | 2014-05-29 | 2017-02-15 | 烟台大学 | 一种含芳胺结构的硫脲类化合物及其制备方法和应用 |
| CN114717264A (zh) | 2014-11-14 | 2022-07-08 | 沃雅戈治疗公司 | 治疗肌萎缩性侧索硬化(als)的组合物和方法 |
| EP3246046A4 (en) * | 2015-01-13 | 2018-12-05 | Kyoto University | Agent for preventing and/or treating amyotrophic lateral sclerosis |
| EP3618839A4 (en) | 2017-05-05 | 2021-06-09 | Voyager Therapeutics, Inc. | COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
| TW202413649A (zh) | 2017-10-16 | 2024-04-01 | 美商航海家醫療公司 | 肌萎縮性脊髓側索硬化症(als)之治療 |
| EP4046688B1 (en) | 2019-10-18 | 2025-04-09 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2688138B1 (fr) | 1992-03-06 | 1995-05-05 | Rhone Poulenc Rorer Sa | Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique. |
| EP2298311B1 (en) | 1999-01-13 | 2012-05-09 | Bayer HealthCare LLC | w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| US7235576B1 (en) * | 2001-01-12 | 2007-06-26 | Bayer Pharmaceuticals Corporation | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US20030236287A1 (en) | 2002-05-03 | 2003-12-25 | Piotrowski David W. | Positive allosteric modulators of the nicotinic acetylcholine receptor |
| US8227643B2 (en) | 2002-05-31 | 2012-07-24 | Proteotech, Inc. | Sirtuin 1 and the treatment of neurodegenerative diseases |
| AU2005225559A1 (en) | 2004-03-29 | 2005-10-06 | Neurosearch A/S | Novel urea derivatives and their medical use |
| JP5704785B2 (ja) * | 2004-07-19 | 2015-04-22 | ザ・ジョンズ・ホプキンス・ユニバーシティ | 免疫抑制のためのｆｌｔ３阻害剤 |
| US8329408B2 (en) * | 2005-10-31 | 2012-12-11 | Bayer Healthcare Llc | Methods for prognosis and monitoring cancer therapy |
| EP2206724A1 (en) | 2005-12-13 | 2010-07-14 | Kyoto University | Nuclear reprogramming factor |
| GB0606429D0 (en) * | 2006-03-30 | 2006-05-10 | Novartis Ag | Organic compounds |
| CA2645633A1 (en) * | 2006-04-05 | 2007-11-01 | Novartis Ag | Combinations of therapeutic agents for treating cancer |
| GB0609378D0 (en) * | 2006-05-11 | 2006-06-21 | Novartis Ag | Organic compounds |
| WO2008031835A2 (en) | 2006-09-13 | 2008-03-20 | Novartis Ag | Method of treating autoimmune diseases using vegf-pathway inhibitors |
| US20080234332A1 (en) * | 2007-03-20 | 2008-09-25 | Xiong Cai | Raf kinase inhibitors containing a zinc binding moiety |
| DK3399025T3 (da) | 2007-03-23 | 2025-06-16 | Wisconsin Alumni Res Found | Omprogrammering af somatiske celler |
| US20090004213A1 (en) * | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| TW200848063A (en) * | 2007-04-23 | 2008-12-16 | Combinatorx Inc | Methods and compositions for the treatment of neurodegenerative disorders |
| US8093425B2 (en) * | 2007-04-30 | 2012-01-10 | Synta Pharmaceuticals Corp. | Compounds for treating proliferative disorders |
| WO2009011893A2 (en) * | 2007-07-17 | 2009-01-22 | Combinatorx, Incorporated | Treatments of b-cell proliferative disorders |
| CN102159556A (zh) | 2008-08-15 | 2011-08-17 | 得克萨斯大学评议会 | 1,4-苯并嗪化合物及其衍生物作为治疗药物用于治疗神经变性病状 |
-
2011
- 2011-09-02 US US13/820,420 patent/US9856210B2/en not_active Expired - Fee Related
- 2011-09-02 WO PCT/JP2011/070538 patent/WO2012029994A1/en not_active Ceased
- 2011-09-02 EP EP11822002.9A patent/EP2611437B1/en not_active Not-in-force
- 2011-09-02 JP JP2011191990A patent/JP5835729B2/ja not_active Expired - Fee Related